Understanding kidney disease progression and improving patient outcomes
Mount Sinai Health System Kidney Precision Medicine Project
This study is looking for people with chronic kidney disease or acute kidney injury to help us learn more about kidney problems by examining kidney tissue, so we can find better ways to support and treat patients like you.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10893441 on NIH RePORTER |
What this research studies
This research focuses on the Kidney Precision Medicine Project at Mount Sinai, which aims to better understand kidney disease by analyzing human kidney tissue. The project will recruit diverse patients with chronic kidney disease (CKD) and acute kidney injury (AKI) to identify disease markers and molecular pathways that contribute to kidney disease. By establishing a patient-centered approach, the research will ensure safety and ethical standards while leveraging existing tools to monitor and support patients at risk for CKD progression.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with chronic kidney disease or acute kidney injury, particularly those with comorbid conditions like diabetes and hypertension.
Not a fit: Patients with stable kidney function and no history of kidney disease may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prediction and treatment options for patients with kidney disease.
How similar studies have performed: Similar research efforts have shown promise in identifying biomarkers for kidney disease, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Coca, Steven G — Icahn School of Medicine at Mount Sinai
- Study coordinator: Coca, Steven G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.